Improving cancer outcomes in areas with persistent poverty
Center for Cancer Control in Persistent Poverty Areas (C3P2)
This study is looking at how living in areas with ongoing poverty affects cancer rates, especially for cancers linked to obesity, and it aims to find ways to help people in these communities prevent and fight cancer better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11082234 on NIH RePORTER |
What this research studies
This research focuses on addressing the higher cancer mortality rates in areas of persistent poverty, particularly for obesity-related cancers like breast, prostate, and colorectal cancer. It aims to understand how social determinants of health and living environments affect health behaviors and cancer risks. The project will implement and evaluate various interventions designed to improve cancer prevention, treatment, and survivorship in these communities. By collaborating with local populations, the research seeks to create tailored solutions that can effectively reduce cancer disparities.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in persistent poverty areas, particularly those at risk for obesity-related cancers.
Not a fit: Patients who do not reside in persistent poverty areas or who are not at risk for obesity-related cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant improvements in cancer outcomes and reduced disparities for patients living in impoverished areas.
How similar studies have performed: Previous research has shown success in addressing cancer disparities through community-based interventions, indicating that this approach has potential for positive outcomes.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Pisu, Maria — University of Alabama at Birmingham
- Study coordinator: Pisu, Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.